Literature DB >> 25952757

Birt-Hogg-Dubé syndrome and intracranial vascular pathologies.

Rahul Kapoor1, Alexander I Evins2, Diala Steitieh1, Antonio Bernardo1, Philip E Stieg1.   

Abstract

Birt-Hogg-Dubé syndrome, first described in 1977, is a rare autosomal dominant condition that commonly presents with skin lesions, including fibrofolliculomas and trichodiscomas; pulmonary cysts; spontaneous pneumothoraces; and renal cancer. We present the only known cases of intracranial vascular pathologies in patients with Birt-Hogg-Dubé syndrome. We present three cases (three female; age range 18-50) of intracranial vascular lesions in Birt-Hogg-Dubé patients, including two aneurysms and one arteriovenous malformation, and review one previously reported case of carotid aplasia. Due to the rarity of Birt-Hogg-Dubé syndrome and significant variations in its clinical presentation, it is difficult to assess whether or not Birt-Hogg-Dubé patients are predisposed to intracranial vascular pathologies. We hypothesize that increased transcription of hypoxia-inducible factor 1-alpha, resulting from a mutated form of the protein folliculin transcribed by the Birt-Hogg-Dubé gene, may be associated with vascular pathogenesis in Birt-Hogg-Dubé patients and thus provide a possible molecular basis for a link between these two conditions.

Entities:  

Keywords:  Aneurysm; Arteriovenous malformation; Birt–Hogg–Dubé; Genetic disorder

Mesh:

Year:  2015        PMID: 25952757     DOI: 10.1007/s10689-015-9807-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  14 in total

1.  Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations.

Authors:  Tomoki Hashimoto; Gen Wen; Michael T Lawton; Nancy J Boudreau; Andrew W Bollen; Guo-Yuan Yang; Nicholas M Barbaro; Randall T Higashida; Christopher F Dowd; Van V Halbach; William L Young
Journal:  Stroke       Date:  2003-03-20       Impact factor: 7.914

2.  Matrix metalloproteinase-9 in cerebral aneurysms.

Authors:  S C Kim; M Singh; J Huang; C J Prestigiacomo; C J Winfree; R A Solomon; E S Connolly
Journal:  Neurosurgery       Date:  1997-09       Impact factor: 4.654

3.  [Hornstein-Knickenberg and Birt-Hogg-Dube syndrome. Report of a case with spontaneous pneumothorax and aplasia of the left internal carotid artery].

Authors:  B Frantzen; C Rose; T Schulz; E B Bröcker; H Hamm
Journal:  Hautarzt       Date:  2001-11       Impact factor: 0.751

4.  Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade.

Authors:  Suzana Pinheiro Pimenta; Bruno Guedes Baldi; Milena Marques Pagliarelli Acencio; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho
Journal:  J Bras Pneumol       Date:  2011 Jul-Aug       Impact factor: 2.624

5.  Pulmonary cysts of Birt-Hogg-Dubé syndrome: a clinicopathologic and immunohistochemical study of 9 families.

Authors:  Mitsuko Furuya; Reiko Tanaka; Shunsuke Koga; Yasushi Yatabe; Hiroko Gotoda; Seiji Takagi; Yung-Hsiang Hsu; Takeshi Fujii; Akira Okada; Naoto Kuroda; Suzuko Moritani; Hideki Mizuno; Yoji Nagashima; Kiyotaka Nagahama; Kenzo Hiroshima; Ichiro Yoshino; Fumio Nomura; Ichiro Aoki; Yukio Nakatani
Journal:  Am J Surg Pathol       Date:  2012-04       Impact factor: 6.394

6.  [Small papular tumors of the perifollicular and perivascular connective tissue of the head and neck area].

Authors:  J Mertens; C Schubert
Journal:  HNO       Date:  1991-07       Impact factor: 1.284

7.  Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.

Authors:  Teppei Nishii; Mikiko Tanabe; Reiko Tanaka; Tetsuhiro Matsuzawa; Koji Okudela; Akinori Nozawa; Yukio Nakatani; Mitsuko Furuya
Journal:  Pathol Int       Date:  2013-01-18       Impact factor: 2.534

8.  [Acute type A aortic dissection with Birt-Hogg-Dubé syndrome; report of a case].

Authors:  Masayuki Sakaguchi; Hirohisa Gotou; Takashi Nakahara; Megumi Fuke; Kazunori Nishimura; Hiroshi Kuraishi; Mitsuko Furuya
Journal:  Kyobu Geka       Date:  2014-05

9.  Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility.

Authors:  R S Preston; A Philp; T Claessens; L Gijezen; A B Dydensborg; E A Dunlop; K T Harper; T Brinkhuizen; F H Menko; D M Davies; S C Land; A Pause; K Baar; M A M van Steensel; A R Tee
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

10.  Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.

Authors:  Seung-Beom Hong; HyoungBin Oh; Vladimir A Valera; Jaime Stull; Duy-Tan Ngo; Masaya Baba; Maria J Merino; W Marston Linehan; Laura S Schmidt
Journal:  Mol Cancer       Date:  2010-06-23       Impact factor: 27.401

View more
  3 in total

1.  Birt-Hogg-Dube syndrome accompanied by pulmonary arteriovenous malformation.

Authors:  Noriyuki Matsutani; Hitoshi Dejima; Yusuke Takahashi; Hirofumi Uehara; Hisae Iinuma; Fumihiko Tanaka; Masafumi Kawamura
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  A Case of Birt-Hogg-Dubé Syndrome and Multiple Intracranial Aneurysms.

Authors:  Nikhil K Murthy; Matthew B Potts; Babak Jahromi
Journal:  Cureus       Date:  2020-02-05

3.  Genetically diagnosed Birt-Hogg-Dubé syndrome and familial cerebral cavernous malformations in the same individual: a case report.

Authors:  James Whitworth; Brian Stausbøl-Grøn; Anne-Bine Skytte
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.